The SA Journal Diabetes & Vascular Disease Volume 18 No 2 (November 2021)

VOLUME 18 NUMBER 2 • November 2021 17 SA JOURNAL OF DIABETES & VASCULAR DISEASE From the Editor’s Desk From the Editor’s Desk Correspondence to: FA Mahomed Head of Internal Medicine, Madadeni Hospital Newcastle, KwaZulu-Natal WHEN ALL THE PARTS FIT... EFFICACY 2 SAFETY 2 PROVEN OUTCOMES 3 PERFECTLY. AMLOC 5, 10 mg. Each tablet contains amlodipine maleate equivalent to 5, 10 mg amlodipine respectively. S3 A38/7.1/0183, 0147. NAM NS2 06/7.1/0011, 0012. BOT S2 BOT 0801198, 0801199. For full prescribing information, refer to the professional information approved by SAHPRA, 29 September 2017. 1) IQVIA MAT Units, Aug 2020. 2) Dahlof B, Sever PS, Poulter NR, et al. for the Ascot investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906. 3) Nissen SE, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: A randomised controlled trial. JAMA 2004;292:2217-2226. ACJ706/01/2021. CUSTOMER CARE LINE 0860 PHARMA (742 762) www.pharmadynamics.co.za T his issue looks at a number of topics. Jinadu et al . (page 18) assessed the use of an ultrasound-determined measure, the resistivity index, to assess renal function in diabetes. Non- invasive and readily available, this measure contributes to the armamentarium of the assessing doctor. Commentary is also given on the use of once-weekly semaglutide (Ozempic ® ) in diabetes (page 25). The interesting aspect here is the degree of weight loss in the real-world setting. We eagerly await this outcome measure. Other areas discussed include intermittent fasting as a weight- loss intervention in gestational diabetes (page 28), the effect of metformin on the outcome of diabetics with Covid-19 disease (page 29), and some results from the EMPEROR-Preserved trial (page 30). Happy Holidays we wish you joy A warm thank you from the management and staff of Clinics Cardive Publishing (publishers of the Cardiovascular Journal of Africa and the South African Journal of Diabetes & Vascular Disease) to our authors, reviewers and clients for your continued support and collaboration. May your holiday season and the new year be filled with much joy, happiness, health and success. Our office will close on 15 December 2021 and open on Monday 17 January 2022. We look forward to being of service to you in the new year.